Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients
Dimitrios Chantzichristos, Andréasson Björn, Johansson Peter
Department of Internal Medicine, Uddevalla Hospital, Uddevalla, Sweden
Background: Once a month, patients with multiple myeloma received an infusion of bisphosphonates, principally to reduce osteoclastic bone resorption. Recommended infusion time for pamidronate is 2 hours in the US and 4 hours in Europe because of its potential nephrotoxicity. From 2003, a 90 mg infusion of pamidronate was provided over 1 hour to patients with no pre-existing renal impairment, in the Daily Care Unit at Uddevalla Hospital.
Method: Retrospective analysis of the renal deterioration, serum calcium, and adverse effects in patients with multiple myeloma treated with 1-hour pamidronate 90 mg infusion from January 2003 to April 2007.
Results: Seventy-nine patients provided valuable data. A total number of 846 infusions were given and the median number of infusion to each patient was 11. Significant creatinine elevation was seen in 7 patients (8.9%), after 19 infusions (2.2%). Renal deterioration occurred in 5 of these 7 patients, which was related to progress of the myeloma or opportunistic infections. Prevalence of infusion-related events was 0.8% and the mean total S-Ca was 0.05 mmol/L lower than the baseline.
Conclusion: Few events of renal deterioration, hypocalcemia, or other adverse effects resulted from a 1-hour pamidronate 90 mg infusion for multiple myeloma patients with no pre-existing renal impairment.
Keywords: bisphosphonates, pamidronate, multiple myeloma, infusion time
Readers of this article also read:
Kulkarni M, Flašker A, Lokar M, Mrak-Poljšak K, Mazare A, Artenjak A, Čučnik S, Kralj S, Velikonja A, Schmuki P, Kralj-Iglič V, Sodin-Semrl S, Iglič A
Published Date: 18 February 2015
Diagnostic accuracy of sensitive or high-sensitive troponin on presentation for myocardial infarction: a meta-analysis and systematic review
Sethi A, Bajaj A, Malhotra G, Arora RR, Khosla S
Published Date: 21 July 2014
Xia S, Li P, Chen Q, Armah M, Ying X, Wu J, Lai J
Published Date: 23 May 2014
Wang H, Gu W, Xiao N, Ye L, Xu Q
Published Date: 18 March 2014
NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency
Burgess BL, He Y, Baker MM, Luo B, Carroll SF, Forte TM, Oda MN
Published Date: 12 December 2013
Bian X, Liang S, John J, Hsiao CH, Wei X, Liang D, Xie H
Published Date: 21 November 2013
Itakura M, Itakura H, Kashima T, Akiyama H, Kishi S
Published Date: 1 July 2013
Mª Rosa Güell Rous
Published Date: 6 June 2008
Prashant Kedia, Russell D Cohen
Published Date: 15 November 2007
Published Date: 15 July 2007